LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $704,000 | -90.6% | 6,900 | -89.0% | 0.04% | -93.1% |
| Q2 2016 | $7,490,000 | +0.5% | 62,800 | -9.8% | 0.59% | +27.0% |
| Q1 2016 | $7,453,000 | +26.8% | 69,600 | +28.4% | 0.47% | -42.0% |
| Q4 2015 | $5,876,000 | +206.2% | 54,200 | +142.0% | 0.80% | +1772.1% |
| Q3 2015 | $1,919,000 | -8.7% | 22,400 | +7.5% | 0.04% | -21.8% |
| Q2 2015 | $2,102,000 | +37.7% | 20,834 | +5.3% | 0.06% | +44.7% |
| Q1 2015 | $1,526,000 | +67.5% | 19,789 | +2.1% | 0.04% | +58.3% |
| Q3 2014 | $911,000 | -12.2% | 19,380 | +16.4% | 0.02% | -14.3% |
| Q2 2014 | $1,037,000 | -36.8% | 16,655 | -56.1% | 0.03% | -37.8% |
| Q3 2013 | $1,641,000 | – | 37,907 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |